title: Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative study.
abstract: Seventy-two patients with seborrheic dermatitis were treated once daily with 2% ketoconazole cream (n = 36) or 1% hydrocortisone cream (n = 36) on a double-blind basis for 4 weeks. For the global evaluation, no significant difference could be seen between the two groups. The clinical response was 80.5% in the ketoconazole group and 94.4% in the hydrocortisone group. For the different symptoms combined (scaling, redness, itching, and papules), no significant difference was seen between the two groups when the total scores at week 2 and at week 4 were compared with the initial scores. The incidence of side effects in both groups was comparably low.
authors.affiliation: A. Sygros Hospital, Athens, Greece.
authors.forename: J D
authors.initials: JD
authors.lastname: Stratigos
authors.forename: C
authors.initials: C
authors.lastname: Antoniou
authors.forename: A
authors.initials: A
authors.lastname: Katsambas
authors.forename: K
authors.initials: K
authors.lastname: Böhler
authors.forename: P
authors.initials: P
authors.lastname: Fritsch
authors.forename: A
authors.initials: A
authors.lastname: Schmölz
authors.forename: D
authors.initials: D
authors.lastname: Michaelidis
authors.forename: K
authors.initials: K
authors.lastname: De Beule
mesh_terms: D000279:Administration, Cutaneous; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006854:Hydrocortisone; D007654:Ketoconazole / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation
chemical_list: D000893:Anti-Inflammatory Agents; D007654:Ketoconazole; D006854:Hydrocortisone